PUBLISHER: IMARC | PRODUCT CODE: 1378823
PUBLISHER: IMARC | PRODUCT CODE: 1378823
The global facial injectables market size reached US$ 7.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.3 Billion by 2028, exhibiting a growth rate (CAGR) of 9.5% during 2022-2028.
Facial injectables are administered on specific areas of the face to enhance the physical appearance of the skin. These injectables are generally made using collagen, hyaluronic acid and calcium hydroxylapatite that help restore the elasticity of the skin. They are used to reduce wrinkles, augment lips, enhance shallow contours and raise depressed scars. Currently, facial injectables are gaining traction worldwide as they are safe, cost-effective and require minimal downtime.
As collagen production and formation of fat under the skin decline with age, the skin becomes more susceptible to wrinkles and sagging. This, in confluence with the growing geriatric population and the desire to retain a young and healthy skin, represents one of the key factors bolstering the market growth. Apart from this, the escalating demand for minimally invasive surgeries, coupled with the rising trend of medical and cosmetic tourism, is contributing to the market growth. Moreover, as excessive sun exposure leads to tissue breakdown of the skin, the demand for facial injectables is escalating among outgoing individuals. Furthermore, inflating disposable incomes, the rising influence of social media, and the growing number of professional practitioners and users willing to try organic and biodegradable materials are some of the other factors influencing the market positively. Besides this, the key players are also offering customized facial injectables to provide a personalized experience to users, which, in turn, is anticipated to create a positive outlook for the market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global facial injectables market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, application type, application and end user.
Collagen
Hyaluronic Acid (HA)
Botulinum Toxin Type A
Calcium Hydroxylapatite (CaHA)
Polymethylmethacrylate Beads (PMMA Microspheres)
Poly-L-Lactic Acid (PLLA)
Others
Aesthetics
Therapeutics
Facial Line Correction
Lip Augmentation
Face Lift
Acne Scar Treatment
Others
Hospitals
Dermatology Clinics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc. and Bausch Health Companies Inc.